The anaplastic lymphoma kinase (ALK) gene translocation is noted in 4–7% of non-small cell lung cancer (NSCLC) cases and results in a fusion between ALK and a second gene (most commonly EML4). Here, EML4 is linked to non-small cell lung carcinoma.